Reuters logo
BRIEF-Exelixis announces initiation of early-stage trial of combination drug
June 12, 2017 / 2:18 PM / 3 months ago

BRIEF-Exelixis announces initiation of early-stage trial of combination drug

June 12 (Reuters) - Exelixis Inc

* Exelixis Inc announces initiation of Phase 1b trial of cabozantinib in combination with atezolizumab in patients with locally advanced or metastatic solid tumors Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below